Waterfall Heather, Grivell Rosalie M, Dodd Jodie M
Women's and Children's Division, Lyell McEwin Hospital, Haydown Road, Elizabeth, SA, Australia.
Cochrane Database Syst Rev. 2016 Jan 31;2016(1):CD004944. doi: 10.1002/14651858.CD004944.pub3.
Caesarean section involves making an incision in the woman's abdomen and cutting through the uterine muscle. The baby is then delivered through that incision. Difficult caesarean birth may result in injury for the infant or complications for the mother. Methods to assist with delivery include vacuum or forceps extraction or manual delivery utilising fundal pressure. Medication that relaxes the uterus (tocolytic medication) may facilitate the birth of the baby at caesarean section. Delivery of the impacted head after prolonged obstructed labour can be associated with significant maternal and neonatal complication; to facilitate delivery of the head the surgeon may utilise either reverse breech extraction or head pushing.
To compare the use of tocolysis (routine or selective use) with no use of tocolysis or placebo and to compare different extraction methods at the time of caesarean section for outcomes of infant birth trauma, maternal complications (particularly postpartum haemorrhage requiring blood transfusion), and long-term measures of infant and childhood morbidity.
We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 September 2015) and reference lists of retrieved studies.
All published, unpublished, and ongoing randomised controlled trials comparing the use of tocolytic agents (routine or selective) at caesarean section versus no use of tocolytic or placebo at caesarean section to facilitate the birth of the baby. Use of instrument versus manual delivery to facilitate birth of the baby. Reverse breech extraction versus head pushing to facilitate delivery of the deeply impacted fetal head.
Two review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy.
Seven randomised controlled trials, involving 582 women undergoing caesarean section were included in this review. The risk of bias of included trials was variable, with some trials not adequately describing allocation or randomisation.Three comparisons were included. 1. Tocolysis versus no tocolysisA single randomised trial involving 97 women was identified and included in the review. Birth trauma was not reported. There were no cases of any maternal side-effect reported in either the nitroglycerin or the placebo group. No other maternal and infant health outcomes were reported. 2. Reverse breech extraction versus head push for the deeply impacted head at full dilation at caesarean section Four randomised trials involving 357 women were identified and included in the review. The primary outcome of birth trauma was reported by three trials and there was no difference between reverse breech extraction and head push for this rare outcome (three studies, 239 women, risk ratio (RR) 1.55, 95% confidence interval (CI) 0.42 to 5.73). Secondary outcomes including endometritis rate (three studies, 285 women, average RR 0.52, 95% CI 0.26 to 1.05, Tau I² = 0.22, I² = 56%), extension of uterine incision (four studies, 357 women, average RR 0.23, 95% CI 0.13 to 0.40), mean blood loss (three studies, 298 women, mean difference (MD) -294.92, 95% CI -493.25 to -96.59; I² = 98%) and neonatal intensive care unit (NICU)/special care nursery (SCN) admission (two studies, 226 babies, average RR 0.53, 95% CI 0.23 to 1.22, Tau I² = 0.27, I² = 74%) were decreased with reverse breech extraction. No differences were observed between groups for many of the other secondary outcomes reported (blood loss > 500 mL; blood transfusion; wound infection; mean hospital stay; average Apgar score).There was significant heterogeneity between the trials for the outcomes mean blood loss, operative time and mean hospital stay, making comparison difficult. However the operation duration was significantly shorter for reverse breech extraction, which may correspond with ease of delivery and therefore, the amount of tissue trauma and therefore, significantly less blood loss. Given the heterogeneity, we cannot define the amount of difference in blood loss, operative time or hospital stay however. 3. Instrument (vacuum or forceps) versus manual extraction at elective caesarean section Two randomised trials involving 128 women were identified and included in the review. Only one trial reported maternal and infant health outcomes as prespecified in this review. This trial reported birth trauma as an outcome but there were no instances of birth trauma in either comparison group. There were no differences found in mean fall in haemoglobin (Hb) between groups (one study, 44 women, MD 0.03, 95% CI -0.53 to 0.59), or in uterine incision extension (one study, 44 women, RR 0.70, 95% CI 0.13 to 3.73).
AUTHORS' CONCLUSIONS: There is currently insufficient information available from randomised trials to support or refute the routine or selective use of tocolytic agents or instrument to facilitate infant birth at the time of difficult caesarean section. There is limited evidence that reverse breech extraction may improve maternal and fetal outcomes, though there was no difference in primary outcome of infant birth trauma. Further randomised controlled trials are needed to answer these questions.
剖宫产需要在产妇腹部做切口,并切开子宫肌层。然后通过该切口娩出胎儿。困难的剖宫产可能导致婴儿受伤或母亲出现并发症。辅助分娩的方法包括真空吸引或产钳助产,或利用宫底加压进行徒手分娩。使子宫松弛的药物(宫缩抑制剂)可能有助于剖宫产时胎儿的娩出。长时间梗阻性分娩后娩出嵌顿胎头可能会导致严重的母婴并发症;为便于胎头娩出,外科医生可采用倒转臀牵引术或推头术。
比较使用宫缩抑制剂(常规或选择性使用)与不使用宫缩抑制剂或安慰剂的效果,并比较剖宫产时不同的助产方法对婴儿出生创伤、母亲并发症(尤其是需要输血的产后出血)以及婴儿和儿童期发病率长期指标的影响。
我们检索了Cochrane妊娠与分娩组试验注册库(2015年9月30日)以及检索到的研究的参考文献列表。
所有已发表、未发表及正在进行的随机对照试验,比较剖宫产时使用宫缩抑制剂(常规或选择性)与不使用宫缩抑制剂或安慰剂以促进胎儿娩出的效果。比较器械助产与徒手助产以促进胎儿娩出的效果。比较倒转臀牵引术与推头术以促进嵌顿较深的胎头娩出的效果。
两位综述作者独立评估试验是否纳入及偏倚风险,提取数据并检查其准确性。
本综述纳入了7项随机对照试验,涉及582例行剖宫产的妇女。纳入试验的偏倚风险各不相同,一些试验未充分描述分配或随机化情况。纳入了三项比较。1. 宫缩抑制剂与不使用宫缩抑制剂一项涉及97名妇女的随机试验被识别并纳入本综述。未报告出生创伤情况。硝酸甘油组和安慰剂组均未报告任何产妇副作用病例。未报告其他母婴健康结局。2. 剖宫产时宫颈完全扩张且胎头嵌顿较深时倒转臀牵引术与推头术四项涉及357名妇女的随机试验被识别并纳入本综述。三项试验报告了出生创伤这一主要结局,对于这一罕见结局,倒转臀牵引术与推头术之间无差异(三项研究,239名妇女,风险比(RR)1.55,95%置信区间(CI)0.42至5.73)。次要结局包括子宫内膜炎发生率(三项研究,285名妇女,平均RR 0.52,95%CI 0.26至1.05,Tau I² = 0.22,I² = 56%)、子宫切口延长(四项研究,357名妇女,平均RR 0.23,95%CI 0.13至0.40)、平均失血量(三项研究,298名妇女,平均差(MD)-294.92,95%CI -493.25至-96.59;I² = 98%)以及新生儿重症监护病房(NICU)/特殊护理病房(SCN)入院率(两项研究,226名婴儿,平均RR 0.53,95%CI 0.23至1.22,Tau I² = 0.27,I² = 74%),倒转臀牵引术可降低这些指标。在报告的许多其他次要结局方面(失血量>500 mL;输血;伤口感染;平均住院时间;平均阿氏评分),两组之间未观察到差异。对于平均失血量、手术时间和平均住院时间这些结局,试验之间存在显著异质性,使得比较困难。然而,倒转臀牵引术的手术持续时间明显更短,这可能与分娩容易程度相关,因此组织创伤量更少,失血量也显著减少。鉴于存在异质性,我们无法确定失血量、手术时间或住院时间的差异量。3. 择期剖宫产时器械(真空或产钳)助产与徒手助产两项涉及128名妇女的随机试验被识别并纳入本综述。只有一项试验报告了本综述预先设定的母婴健康结局。该试验将出生创伤作为一项结局,但两个比较组均未出现出生创伤情况。两组之间在血红蛋白(Hb)平均下降值方面未发现差异(一项研究,44名妇女,MD 0.03,95%CI -0.53至0.59),在子宫切口延长方面也未发现差异(一项研究,44名妇女,RR 0.70,95%CI 0.13至3.73)。
目前随机试验提供的信息不足,无法支持或反驳在困难剖宫产时常规或选择性使用宫缩抑制剂或器械助产以促进婴儿娩出。有有限的证据表明倒转臀牵引术可能改善母婴结局,尽管在婴儿出生创伤这一主要结局方面无差异。需要进一步的随机对照试验来回答这些问题。